Published in Medscape J Med on May 13, 2008
Chelation: harnessing and enhancing heavy metal detoxification--a review. ScientificWorldJournal (2013) 0.83
Clawing back: broadening the notion of metal chelators in medicine. Curr Opin Chem Biol (2013) 0.83
Fatalities after CAM: an overview. Br J Gen Pract (2011) 0.82
Prevention of biliary stent occlusion. Dig Dis Sci (2012) 0.81
Efficacy of reversal of aortic calcification by chelating agents. Calcif Tissue Int (2013) 0.79
Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. J Control Release (2014) 0.78
Synthesis and Crystal Structure of the Bioinorganic Complex [Sb(Hedta)]·2H2O. Bioinorg Chem Appl (2014) 0.75
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2004) 17.79
Equipoise and the ethics of clinical research. N Engl J Med (1987) 17.24
Complementary and alternative medicine use among adults: United States, 2002. Adv Data (2004) 17.17
Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc (2009) 15.16
Ethics and clinical research. N Engl J Med (1966) 12.75
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA (2007) 11.87
Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med (1999) 6.50
Toward evidence-based medical statistics. 2: The Bayes factor. Ann Intern Med (1999) 5.78
Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial. Circulation (1994) 3.51
Rehabilitating equipoise. Kennedy Inst Ethics J (2003) 3.29
Vitamin C exhibits pro-oxidant properties. Nature (1998) 3.22
Chelation therapy for ischemic heart disease: a randomized controlled trial. JAMA (2002) 3.13
Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. Ann Intern Med (2013) 3.08
An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med (1959) 3.04
Vitamin A intake and hip fractures among postmenopausal women. JAMA (2002) 2.90
Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation (2002) 2.80
Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat Res (1996) 2.68
Surgery as placebo. A quantitative study of bias. JAMA (1961) 2.48
Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2006) 2.40
Chelation therapy for coronary heart disease: An overview of all clinical investigations. Am Heart J (2000) 2.40
Science and government. Review for NCCAM is overdue. Science (2006) 2.34
Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort. Am J Clin Nutr (2002) 2.29
Comparison of internal mammary artery ligation and sham operation for angina pectoris. Am J Cardiol (1960) 2.10
Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest (1986) 2.01
EDTA treatment of intermittent claudication--a double-blind, placebo-controlled study. J Intern Med (1992) 1.97
Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J (1999) 1.94
Chelation therapy for intermittent claudication-a reappraisal. N Z Med J (1996) 1.93
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr (2001) 1.82
Chelation therapy for peripheral arterial occlusive disease: a systematic review. Circulation (1997) 1.70
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med (1982) 1.47
Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis. Am J Surg (1991) 1.45
Mechanism of the catalytic oxidation of adrenaline by ferritin. J Biol Chem (1956) 1.45
Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003-2005. MMWR Morb Mortal Wkly Rep (2006) 1.43
So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy. Ann Pharmacother (1993) 1.43
Chelation therapy for intermittent claudication. N Z Med J (1994) 1.39
Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid. Am J Med Sci (1956) 1.34
Angina pectoris and the placebo effect. N Engl J Med (1979) 1.22
The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord (2005) 1.18
The in vivo dissolution of metastatic calcium; an approach to atherosclerosis. Am J Med Sci (1955) 1.14
EDTA chelation therapy in chronic degenerative disease. Med Hypotheses (1988) 1.07
The treatment of coronary artery disease with disodium EDTA. A reappraisal. Am J Cardiol (1963) 1.07
The placebo effect in cardiovascular disease. Am Heart J (1996) 1.05
Chelation endarterectomy for occlusive atherosclerosis. J Am Geriatr Soc (1966) 1.01
The irrelevance of equipoise. J Med Philos (2007) 0.96
[EDTA treatment of arteriosclerosis. Bias or manipulation?]. Ugeskr Laeger (1992) 0.96
Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy. J Am Coll Cardiol (2003) 0.96
So-called "clinical equipoise" and the argument from design. J Med Philos (2007) 0.95
Chelation therapy for arteriosclerosis. JAMA (1975) 0.95
Clinical equipoise and the incoherence of research ethics. J Med Philos (2007) 0.94
Lesions resembling vitamin B complex deficiency and urinary loss of zinc produced by ethylenediamine tetra-acetate. Am J Med (1957) 0.94
The case against laetrile: the fraudulent cancer remedy. Cancer (1980) 0.92
Vitamin C-driven free radical generation from iron. J Nutr (1996) 0.91
Toxic side effects of ethylenedia minetetraacetic acid. J Chronic Dis (1963) 0.91
Editorial: Chihuahuas and laetrile, chelation therapy, and honey from Boulder, Colo. Arch Intern Med (1976) 0.88
Equipoise and the duty of care in clinical research: a philosophical response to our critics. J Med Philos (2007) 0.88
Treatment of occlusive vascular disease with disodium ethylene diamine tetraacetic acid (EDTA). Am J Med Sci (1960) 0.87
Science and government. Enhanced: in defense of NCCAM. Science (2006) 0.87
Laetrile treatment for cancer. Cochrane Database Syst Rev (2006) 0.86
Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover. Dan Med Bull (1993) 0.86
Bilateral internal mammary artery ligation for angina pectoris; preliminary clinical considerations. Am J Cardiol (1958) 0.84
Chelation therapy in the JCR:LA-cp rat: experimental assessment of a putative antiatherosclerotic treatment. Clin Invest Med (2000) 0.83
Clinical evaluation of chelation therapy: is there any wheat amidst the chaff? Am Heart J (2000) 0.83
Adverse effects in 5 patients receiving EDTA at an outpatient chelation clinic. Vet Hum Toxicol (2002) 0.82
CHELATION THERAPY OF OCCLUSIVE ARTERIOSCLEROSIS IN DIABETIC PATIENTS. Angiology (1964) 0.81
A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease. J Natl Med Assoc (1990) 0.80
Potential uses of chelation methods in the treatment of cardiovascular diseases. Prog Cardiovasc Dis (1961) 0.80
Metals in medicine. Altern Ther Health Med (2005) 0.79
The placebo effect in heart failure. Am Heart J (1990) 0.79
Chelation therapy for vascular disease. Circulation (1999) 0.79
The effect of EDTA on the oxidation of low density lipoprotein. Atherosclerosis (1992) 0.78
Evidence and alternative medicine. Mt Sinai J Med (1995) 0.78
Antioxidant vitamin supplements: update of their potential benefits and possible risks. Drug Saf (1999) 0.78
Sounding boards. After laetrile, what? N Engl J Med (1982) 0.77
The effects of magnesium sulphate and EDTA in the hypercholesterolaemic rabbit. Diabetes Obes Metab (2001) 0.77
Bilateral ligation of the internal mammary artery in the treatment of angina pectoris. Experimental and clinical results. Am J Cardiol (1960) 0.77
Atherosclerosis, occlusive vascular disease and EDTA. Am J Cardiol (1960) 0.77
Hypoglycaemia induced by disodium ethylenediamine tetraacetic acid. Lancet (1961) 0.77
Studies in human and induced atherosclerosis employing ethylenediaminetetraacetic acid. Bull Schweiz Akad Med Wiss (1957) 0.76
Chelation therapy. Circulation (1995) 0.76
Chelation therapy. Circulation (1995) 0.76
Questionable methods of cancer management: the Committee for Freedom of Choice in Medicine, Inc. CA Cancer J Clin (1993) 0.76
BOARD of Medical Examiners of the State of North Carolina, Medical Practice Act with 1953 amendments. N C Med J (1953) 0.76
Advances in medical fraud: chelation therapy replaces Laetrile. J Fla Med Assoc (1986) 0.76
Chelation clinics. An abuse of the physician's freedom of choice. Chest (1984) 0.76
Chelation therapy in circulatory and sclerosing diseases. Fed Proc (1961) 0.76
Controlled studies on the efficacy of bilateral internal mammary artery ligation in patients with angina pectoris. Angiology (1959) 0.76
Online laetrile vendor ordered to shut down. FDA Consum (2001) 0.76
The long term use, side effects, and toxicity of disodium ethylenediamine tetraacetic acid (EDTA). Am J Med Sci (1961) 0.75
Chelation therapy for patients with ischemic heart disease. JAMA (2002) 0.75
Chelation therapy for degenerative vascular disease. N Z Med J (1982) 0.75
Dancing with a dream: the folly of pursuing alternative medicine. Acad Med (2001) 0.75
Diagnostic and therapeutic technology assessment. Chelation therapy. JAMA (1983) 0.75
Homeopathic vs conventional treatment of vertigo. Arch Otolaryngol Head Neck Surg (2003) 1.14
Ethical flaws in the TeGenero trial. Am J Bioeth (2007) 0.79
In pediatric fatality, edetate disodium was no accident. Clin Toxicol (Phila) (2009) 0.75
The current system is nuts (excerpt: full version at www.ccjm.org). Cleve Clin J Med (2008) 0.75
Research ethics boards: no data on quality of for-profit or non-profit IRBs. PLoS Med (2006) 0.75
Inappropriate diagnosis and chelation treatment of alleged heavy-metal toxicity. Ann Intern Med (2009) 0.75